Back to Search
Start Over
Towards a comprehensive routine outcome monitoring program for people with psychotic disorders: The Pharmacotherapy Monitoring and Outcome Survey (PHAMOUS)
- Source :
- Schizophrenia Research, 197, 281-287. ELSEVIER SCIENCE BV
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
-
Abstract
- Background: Patients with psychotic disorders are at risk of developing mental health and social problems, and physical disorders. To monitor and treat these problems when indicated, an annual routine outcome monitoring program, Pharmacotherapy Monitoring and Outcome Survey (PHAMOUS), was developed. This paper presents the background and content of PHAMOUS, implementation of PHAMOUS, characteristics of the patients screened in 2015, and the outcome of patients with three annual screenings between 2011 and 2015.Methods: PHAMOUS was implemented in four mental health institutions in the Northern Netherlands in 2006. During the PHAMOUS screening, patients are assessed on socio- demographics, psychiatric symptoms, medication, physical parameters, lifestyle, (psycho) social functioning and quality of life, using internationally validated instruments.Results: In 2015, 1955 patients with psychotic disorders were enrolled in the PHAMOUS screening. The majority (72%) was receiving mental healthcare for ten years or longer. A small group was hospitalized (10%) in the past year. Half of the patients were in symptomatic remission. Less than 10% had a paid job. More than half of the patients fulfilled the criteria for metabolic syndrome (54%). The subsamplewith three annual screenings from2011 to 2015 (N= 1230) was stable, except the increasing prevalence of high glucose levels and satisfaction with social relationships (Cochran's Q= 16.33, p=. 001 resp. Q= 14.79, p =.001).Conclusion: The annual PHAMOUS screening enables to follow themental, physical and social health problems of patients, which offers a good basis for shared- decision making with regard to updating the annual treatment plan, next to a wealth of data for scientific research. (C) 2018 Elsevier B. V. All rights reserved.
- Subjects :
- Male
Comorbidity
law.invention
0302 clinical medicine
Randomized controlled trial
Quality of life
law
Outcome Assessment, Health Care
Program Development
Netherlands
Metabolic Syndrome
SEVERE MENTAL-ILLNESS
ASSOCIATION
RANDOMIZED CONTROLLED-TRIAL
Middle Aged
CANNABIS USE
Psychiatry and Mental health
Cardiovascular diseases
Schizophrenia
ANTIPSYCHOTICS QUESTIONNAIRE
Female
HEALTH
Antipsychotic Agents
Adult
Mental Health Services
medicine.medical_specialty
Social issues
Routine outcome monitoring
03 medical and health sciences
Pharmacotherapy
Severe mental illness
medicine
Humans
Interpersonal Relations
Social determinants of health
Biological Psychiatry
SUBJECTS RESPONSE
business.industry
medicine.disease
Health Surveys
Mental health
Annual Screening
030227 psychiatry
Psychotic Disorders
Family medicine
RISK-FACTORS
Quality of Life
business
030217 neurology & neurosurgery
Follow-Up Studies
Subjects
Details
- ISSN :
- 09209964
- Volume :
- 197
- Database :
- OpenAIRE
- Journal :
- Schizophrenia Research
- Accession number :
- edsair.doi.dedup.....046751c26c098b78dd417f4bdce98f28